This is an old revision of this page, as edited by Vaccinationist (talk | contribs) at 20:43, 14 December 2015. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
 | This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Temocapril" – news · newspapers · books · scholar · JSTOR (December 2015) (Learn how and when to remove this template message) |
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C23H28N2O5S2 |
| Molar mass | 476.608 g/mol g·mol−1 |
| (verify) | |
Temocapril (also known as temocaprilum [Latin]; brand name Acecol) is an ACE inhibitor. It was not approved for use in the US.
| ACE inhibitors ("-pril") |
|
|---|---|
| AIIRAs ("-sartan") | |
| Renin inhibitors ("-kiren") | |
| Dual ACE/NEP inhibitors | |
| Neprilysin inhibitors | |
| |
 | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
